A U.S. House subcommittee on Tuesday weighed whether to grant the Food and Drug Administration more authority to mandate safety recalls of cosmetic products, including asbestos-containing talcum powder.
The hearing before the Subcommittee on Economic and Consumer Policy in the U.S. House of Representatives’ Committee on Oversight and Reform, comes after the FDA last week warned consumers in a safety alert that four cosmetic products from retailers Claire’s and Justice contained asbestos, a known carcinogen. (Claire’s voluntarily recalled the products on Monday.)
